Dr. Nils Haep is passionate about liver research and strives to understand genetic influences in non-alcoholic steatohepatitis. He is fascinated in using tissue engineering techniques to create novel disease models. Recently, he developed and patented a transcriptional gene therapy for liver failure, with the goal of helping patients with end-stage liver disease.
Dr. Haep graduated from Heinrich-Heine-Universität Düsseldorf with a medical degree in 2015. Then, he started his training in General, Visceral, and Transplantation Surgery at Charité – Universitaetsmedizin Berlin's Department of General, Visceral, and Transplantation Surgery (Director: Prof. Pratschke). In 2020, he successfully defended his thesis (promotion), "The EphB-recpetors and their function for the podocyte". Dr. Haep completed postdoctoral training in the lab of Prof. Soto-Gutierrez at the University of Pittsburgh's liver research center between 2019 and 2022.